Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes

Free Radical Biology and Medicine

Volumn 24, Issue 7-8, 1998, Pages 1324-1330

  Puntarulo, Susana ^a   Cederbaum, Arthur I ^b  

^a Laboratory of Free Radical Biology   (Argentina)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CYP1A1; CYP1A2; CYP2B6; CYP3A4; Free radical; Human cytochrome P450s; Iron reduction; Reactive oxygen species; Superoxide anion

Indexed keywords

CYTOCHROME; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2B6; CYTOCHROME P450 3 A 4; HEMOPROTEIN; LIVER ENZYME; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CELL METABOLISM; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; HUMAN; MICROSOME; OXIDATION; PRIORITY JOURNAL; REDUCTION;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0032077936     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00463-2     Document Type: Article

References (42)

1. Yang C. S., Lu A. Y. H. The diversity of substrates for cytochrome P450. 1987;1-18 CRC Press, Boca Raton, FL.
2. Guengerich F. P. Cytochrome P450 Advances and prospects . FASEB J. 6:1992;667-668.
3. Nelson, D. R.; Kamataki, T.; Waxman, D. J.; Guengerich, F. P.; Estabrook, R. W.; Feyereisen, R.; Gonzalez, F. J.; Coon, M. J.; Gunsalus, I. C.; Gotoh, O. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature (Review). DNA Cell Biol. 12:1-51; 1992.
4. Porter T. D., Coon M. J. Cytochrome P450 Multiplicity of isoforms, substrates and catalytic and regulatory mechanisms . J. Biol. Chem. 266:1991;13469-13472.
5. Guengerich F. P., Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem. Res. Toxicol. 4:1991;391-407.
6. Gonzalez F. Human cytochromes P450 Problems and prospects . TIPS Rev. 13:1992;346-352.
7. Aoyama T., Yamano S., Guzelian P. S., Gelboin H. V., Gonzalez F. J. Five of 12 forms of vaccinia-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. Proc. Natl. Acad. Sci. USA. 87:1990;4790-4793.
8. Chang T. K. M., Weber G. F., Crespi C. L., Waxman D. J. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Res. 53:1993;5629-5637.
9. Halkier B. A. Catalytic activities and structure/function relationships of cytochrome P450 enzymes. Phytochemistry. 43:1996;1-21.
10. White R. E., Coon M. J. Oxygen activation by cytochrome P450. Ann. Rev. Biochem. 49:1980;315-356.
11. Smith G. C. M., Tew D. G., Wolf C. R. Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains. Proc. Natl. Acad. Sci. USA. 91:1994;8710-8714.
12. Buters J. T. M., Korzekwa K. R., Kunze K. L., Omata Y., Hardwick J. P., Gonzalez F. J. cDNA-directed expressions of human cytochrome P450 CYP3A4 using baculovirus. Drug Metab. Dispos. 22:1994;688-692.
13. Renaud J. P., Peyronneau M. A., Urban P., Truan G., Cullin C., Pompon D., Beaune P., Mansuy D. Recombinant yeast in drug metabolism. Toxicology. 82:1993;39-52.
14. Gillian E. M. J., Baba T., Kim B. R., Ohmori S., Guengerich F. P. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305:1993;123-131.
15. Rashba-Step J., Cederbaum A. I. Generation of reactive oxygen intermediates by human liver microsomes in the presence of NADPH or NADH. Molec. Pharmacol. 45:1994;150-157.
16. Ekstrom G., Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P450. Biochem. Pharmacol. 38:1989;1313-1319.
17. Albano E., Tomasi A., Persson J. O., Goria-Gatti L., Ingelman-Sundberg M., Dianzani M. U. Role of ethanol-inducible cytochrome P450 in catalyzing free radical activation of aliphatic alcohols. Biochem. Pharmacol. 41:1991;1895-1902.
18. Gorsky L. D., Koop D. R., Coon M. J. On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P450. J. Biol. Chem. 259:1984;6812-6817.
19. Ohmori S., Misaizu T., Nakamura T., Takano N., Kitagawa H., Kitada M. Differential role in lipid peroxidation between rat P4501A1 and P4501A2. Biochem. Pharmacol. 46:1993;55-60.
20. 1-450 Complementary DNA and amino acid sequence . Science. 228:1985;80-83.
21. 3-450 cDNA and complete amino acid sequence . Nucl. Acid Res. 14:1986;6773-6774.
22. Yamano S., Nhamburo P. T., Aoyama T., Meyer U. A., Inaba T., Kalow W., Gelboin H. V., McBride O. W., Gonzalez F. J. cDNA cloning and sequence and cDNA-directed expression of human P450 II B1: identification of a normal and two variant cDNAs derived from CYP 2B locus on chromosome 19 and differential expression of the II B mRNAs in human liver. Biochemistry. 28:1989;7340-7348.
23. Gonzalez F. J., Schmid B. J., Umeno M., McBride O. W., Hardwick J. P., Meyer U. R. S. A., Gelboin H. V., Idle J. R. Human P450 PCN1. Sequence, chromosome localization and direct evidence through cDNA expression that P450 PCN1 is nifedipine oxidase. DNA. 7:1988;79-86.
24. Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239:1964;2379-2385.
25. Phillips A. H., Langdon R. G. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: Isolation, characterization and kinetic studies. J. Biol. Chem. 237:1962;2652-2660.
26. Lebel C., Bondy S. C. Sensitive and rapid quantitation of oxygen reactive species in rat synaptosomes. Neurochem. Int. 17:1990;435-440.
27. Puntarulo S., Cederbaum A. I. Inhibition of ferritin-stimulated microsomal production of reactive oxygen intermediates by nitric oxide. Arch. Biochem. Biophys. 340:1997;19-26.
28. Puntarulo S., Cederbaum A. I. Comparison of the ability of ferric complexes to catalyze microsomal chemiluminescence, lipid peroxidation and hydroxyl radical generation. Arch. Biochem. Biophys. 264:1988;482-491.
29. Kuthan H., Ullrich V. Oxidase and oxygenase function of the microsomal cytochrome P-450 monooxygenase system. Eur. J. Biochem. 126:1982;583-588.
30. Cadenas E., Boveris A., Chance B. Low level chemiluminescence in biological systems. Pryor W. A. Free Radicals in Biology. Vol. 6:1984;211-247 Academic Press, San Diego.
31. Aust S. D., Morehouse L. A., Thomas C. E. Role of metals in oxygen radical reactions. Free Radic. Biol. Med. 1:1985;3-25.
32. Ryan T. P., Aust S. D. The role of iron in oxygen-mediated toxicities. Crit. Rev. Toxicol. 32:1992;119-141.
33. Kim Y. M., Bergonia H. A., Muller C., Pitt B. R., Watkis W. D., Lancaster J. R. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J. Biol. Chem. 270:1995;5710-5713.
34. Wink D. A., Osawa Y., Darbyshire J. F., Jones C. R., Eshenaur S. C., Nims R. W. Inhibition of cytochrome P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys. 300:1993;115-123.
35. Loida P. J., Sligar S. G. Molecular recognition in cytochrome P-450. Mechanism for the control of uncoupling reactions. Biochemistry. 32:1993;11530-11538.
36. Rao D. N. R., Yang M.-X., Lasker J. M., Cederbaum A. I. 1-Hydroxyethyl radical formation during NADPH- and NADH-dependent oxidation of ethanol by human liver microsomes. Molec. Pharmacol. 49:1996;814-821.
37. 5 on the stoichiometry of P4502E1-catalyzed reactions . Arch. Biochem. Biophys. 317:1995;504-513.
38. Carriere V., Berthou F., Baird S., Belloe C., Beaune P., Waziers I. Human cytochrome P450 2E1 (CYP2E1) From genotype to phenotype . Pharmacogenetics. 6:1996;203-211.
39. Guengerich F. P., Turvy C. G. Comparison of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease state using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256:1991;1189-1194.
40. Shimada T., Yamazaki H., Minura M., Inui Y., Guengerich F. P. Inter-individual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals studies with liver microsomes of 30 Japanese and 30 Caucasians . J. Pharmacol. Exp. Ther. 270:1994;414-423.
41. McLemore T. L., Adelberg S., Liu M. C., McMahon N. A., Yu S. J., Hubbard W. C., Czerwinski M., Wood T. G., Storeng R., Lubet R. A., Eggleston J. C., Boyd M. R., Hines R. N. Expression of CYP1A1 gene in patients with lung cancer evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas . J. Natl. Cancer Inst. 82:1990;1333-1339.
42. Shimada T., Yun C. H., Yamazaki H., Gautier J. C., Beaune P. H., Guengerich F. P. Characterization of human lung microsomal cytochrome P-4501A1 and its role in the oxidation of chemical carcinogens. Molec. Pharmacol. 41:1992;856-864.